SCHEMBL13300660

SCHEMBL13300660

O=C(Nc1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1Cl)c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 6/20 0.73
▸ PTK2 Q05397 2/20 0.71
▸ PKMYT1 Q99640 2/20 0.71
▸ INSR P06213 1/20 0.71
▸ IGF1R P08069 1/20 0.71
▸ PTK2B Q14289 1/20 0.71
▸ MAPK8 P45983 2/20 0.71
▸ MAPK9 P45984 2/20 0.71
▸ MAPK10 P53779 2/20 0.71
▸ SLC2A1 P11166 1/20 0.70
▸ CCNK O75909 1/20 0.68
▸ CCNA2 P20248 1/20 0.68
▸ CDK2 P24941 1/20 0.68
▸ CCND3 P30281 1/20 0.68
▸ CDK9 P50750 1/20 0.68
▸ CDK6 Q00534 1/20 0.68
▸ MAP3K7 O43318 4/20 0.66
▸ MAPK1 P28482 2/20 0.66
▸ MAP2K1 Q02750 2/20 0.66
▸ ULK1 O75385 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13300747 0.94 PKMYT1 (0.71) EGFRPTK2PKMYT1INSRIGF1R
SCHEMBL13321202 0.91 EGFR (0.60) EGFRPTK2PKMYT1INSRIGF1R
SCHEMBL13300743 0.89 MAPK8 (0.71) EGFRPTK2PKMYT1INSRIGF1R
SCHEMBL13300661 0.86 MAPK8 (0.70) EGFRPTK2PKMYT1INSRIGF1R
SCHEMBL13300667 0.86 PKMYT1 (0.70) EGFRPTK2PKMYT1INSRIGF1R
SCHEMBL13300588 0.86 MAPK8 (0.70) EGFRPTK2PKMYT1INSRIGF1R
SCHEMBL13300671 0.86 PKMYT1 (0.70) EGFRPTK2PKMYT1INSRIGF1R
SCHEMBL13320864 0.86 PKMYT1 (0.58) EGFRPTK2PKMYT1INSRIGF1R
SCHEMBL13300736 0.85 MAPK9 (0.69) EGFRPTK2PKMYT1INSRIGF1R
SCHEMBL3337236 0.85 MAPK8 (0.66) EGFRPTK2PKMYT1INSRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144732-A1 PYRIMIDINE KINASE INHIBITORS GENENTECH, INC. 2010-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144732-A1 PYRIMIDINE KINASE INHIBITORS DTYMK, DCK, TYMP EGFR 1008/4885PTK2 796/4885PKMYT1 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback